Volume 133, Issue 4, Pages (October 2007)

Slides:



Advertisements
Similar presentations
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Hunger Games: Is Your Stomach Making You Fat?
Volume 152, Issue 4, Pages (March 2017)
Transsphincteric pH Profile at the Gastroesophageal Junction
Volume 146, Issue 3, Pages (March 2014)
Outcomes Among Living Liver Donors
Gastric Emptying Clinical Gastroenterology and Hepatology
Volume 136, Issue 7, Pages (June 2009)
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Effect of Peptide YY3–36 on Food Intake in Humans
Covering the Cover Gastroenterology
Volume 154, Issue 5, Pages (April 2018)
Clinical Challenges and Images in GI
Unusual Case of an Upset Stomach
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 131, Issue 6, Pages (December 2006)
Abdominal Pain in a Patient 13 Years After Roux-en-Y Gastric Bypass
A Rare Cause of Postprandial Abdominal Pain and Nausea
Clinical Challenges and Images in GI
Brian M. Fung, Nora Ostrzega, James H. Tabibian  Gastroenterology 
Colon Cancer: An Update and Future Directions
Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans  Christine Feinle, Thomas Rades, Bärbel.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Covering the Cover Gastroenterology
Postprandial Uridine Physiology Is Altered by Obesity
Ingmar Mederacke, Michael P. Manns, Bernhard Meyer  Gastroenterology 
The 75th Diamond Anniversary of Gastroenterology: 1943–2018
Volume 130, Issue 1, Pages (January 2006)
Shabana F. Pasha, Tisha N. Lunsford, Vanda A. Lennon  Gastroenterology 
Volume 152, Issue 4, Pages (March 2017)
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 119, Issue 4, Pages (October 2000)
Volume 148, Issue 3, Pages (March 2015)
Volume 131, Issue 5, Pages (November 2006)
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
Electronic Clinical Challenges and Images in GI
Gastric Rupture Gastroenterology
Volume 150, Issue 7, Pages (June 2016)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Volume 156, Issue 6, Pages e1 (May 2019)
Diagnostic Colonoscopy: The End Is Coming
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Clinical Challenges and Images in GI
Swaroop Pendyala, Jeanne M. Walker, Peter R. Holt  Gastroenterology 
Volume 156, Issue 4, Pages (March 2019)
Changing of the Guards: 2011–2016 Gastroenterology Team
Risks Associated With Anesthesia Services During Colonoscopy
Volume 156, Issue 4, Pages (March 2019)
Electronic Clinical Challenges and Images in GI
Volume 156, Issue 3, Pages (February 2019)
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 155, Issue 6, Pages (December 2018)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Electronic Clinical Challenges and Images in GI
Volume 152, Issue 4, Pages (March 2017)
Controversies in Liver Transplantation for Hepatitis C
Amir Klein, Michael J. Bourke  Gastroenterology 
Electronic Clinical Challenges and Images in GI
Pao-Ying Lin, Chun-Chao Chang, Jean-Dean Liu  Gastroenterology 
The Stomach in Diabetes: From Villain to Ally
Presentation transcript:

Volume 133, Issue 4, Pages 1124-1131 (October 2007) Free Fatty Acids Have More Potent Effects on Gastric Emptying, Gut Hormones, and Appetite Than Triacylglycerides  Tanya J. Little, Antonietta Russo, James H. Meyer, Michael Horowitz, Douglas R. Smyth, Max Bellon, Judith M. Wishart, Karen L. Jones, Christine Feinle–Bisset  Gastroenterology  Volume 133, Issue 4, Pages 1124-1131 (October 2007) DOI: 10.1053/j.gastro.2007.06.060 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Outline of the study protocol. At t = −10 minutes, a baseline blood sample was collected and a VAS questionnaire completed. At t = −5 minutes, a meal containing either (1) 40 g FFA, (2) 40 g TG, both as 600-mL oil-in-water emulsions, stabilized with 4% (wt/vol) powered milk protein and labeled with 15 MBq 123I, or (3) control solution (24 g skim milk powder in 600 mL water, labeled with 15 MBq 99mTc–sulfur colloid) was administered intragastrically. Static images to evaluate gastric emptying and intragastric meal distribution were acquired at t = 0, 10, 20, 30, 45, 60, 90, 120, 150, 180, 210, and 240 minutes. Blood samples for measurement of plasma CCK and PYY levels were collected at t = −10, 0, 10, 20, 30, 45, 60, 90, 120, 180, and 240 minutes and a VAS was administered at t = 0, 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 210, and 240 minutes. At t = 240 minutes, subjects were presented with a cold, buffet-style meal. At t = 270 minutes, a final blood sample was collected and a VAS was completed. Gastroenterology 2007 133, 1124-1131DOI: (10.1053/j.gastro.2007.06.060) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 GE (% retention) (A) after intragastric administration of (1) 40 g FFA, (2) 40 g TG, both as 600-mL oil-in-water emulsions, stabilized with 4% (wt/vol) powered milk protein, or (3) control solution (24 g skim milk powder in 600 mL water), and retention of the fat component of TG and FFA in the (B) proximal and (C) distal stomach. Data are means ± SEM (n = 9). *FFA and TG vs control, #FFA vs TG: P < .001. ♢, Control; ■, TG; ○, FFA. Gastroenterology 2007 133, 1124-1131DOI: (10.1053/j.gastro.2007.06.060) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Grams of fatty acid emptied after intragastric administration of (1) 40 g FFA or (2) 40 g TG, both as 600-mL oil-in-water emulsions, stabilized with 4% (wt/vol) powered milk protein. Data are means ± SEM (n = 9). #FFA vs TG: P < .05. ■, TG; ○, FFA. Gastroenterology 2007 133, 1124-1131DOI: (10.1053/j.gastro.2007.06.060) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Plasma concentrations of (A) CCK and (B) PYY after intragastric administration of (1) 40 g FFA, (2) 40 g TG, both as 600-mL oil-in-water emulsions, stabilized with 4% (wt/vol) powered milk protein, or (3) control solution (24 g skim milk powder in 600 mL water). Data for CCK are changes from baseline values. Data are means ± SEM (n = 9). *FFA vs control, #FFA vs TG, ^control vs TG: P < .05. ♢, Control; ■, TG; ○, FFA. Gastroenterology 2007 133, 1124-1131DOI: (10.1053/j.gastro.2007.06.060) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 (A) Hunger and (B) fullness after intragastric administration of (1) 40 g FFA, (2) 40 g TG, both as 600-mL oil-in-water emulsions, stabilized with 4% (wt/vol) powered milk protein, or (3) control solution (24 g skim milk powder in 600 mL water). Data are means ± SEM (n = 9). *FFA vs control, #FFA vs TG: P < .05. ♢, Control; ■, TG; ○, FFA. Gastroenterology 2007 133, 1124-1131DOI: (10.1053/j.gastro.2007.06.060) Copyright © 2007 AGA Institute Terms and Conditions